GENEVA, July 2 -- ORIGSTONE BIOTECHNOLOGY (ZHEJIANG) CO., LTD filed a patent application (CN2025/133149) for “IMMUNE CELLS EXPRESSING NON-SECRETORY IL-10 FOR ENHANCING CELLULAR IMMUNOTHERAPY, AND PREPARATION METHOD THEREFOR AND USE THEREOF”. With publication no. WO/2026/129931, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12N 5/10
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....